From the archive, originally posted by: [ spectre ]
WILL STILL SUCK YOUR BLOOD
GM mosquito ‘could fight malaria’ / 19 March 2007
A genetically modified (GM) strain of malaria-resistant mosquito has
been created that is better able to survive than disease-carrying
The GM mosquitoes could be identified by their green fluorescent eyes.
It gives new impetus to one strategy for controlling the disease:
introduce the GM insects into wild populations in the hope that they
will take over.
The insect carries a gene that prevents infection by the malaria
Details of the work by a US team appear in Proceedings of the National
Academy of Sciences journal.
The researchers caution that their studies are still at an early
stage, and that it could be 10 years or more before engineered insects
are released into the environment.
“What we did was a laboratory, proof-of-principle experiment; we’re
not anywhere close to releasing them into the wild right now,” co-
author Dr Jason Rasgon from Johns Hopkins University in Baltimore,
Maryland, told BBC News.
The approach exploits the fact that the health of infected mosquitoes
is itself compromised by the parasite they spread. Insects that cannot
be invaded by the parasite are therefore likely to be fitter and out-
compete their disease-carrying counterparts.
In the team’s experiments, equal numbers of genetically modified and
ordinary “wild-type” mosquitoes were allowed to feed on malaria-
As they reproduced, more of the GM, or transgenic, mosquitoes
survived. After nine generations, 70% of the insects belonged to the
The scientists also inserted the gene for green fluorescent protein
(GFP) into the transgenic mosquitoes which made their eyes glow green.
This helped the researchers to easily count the transgenic and non-
Lead author Dr Mauro Marrelli and his colleagues wrote in PNAS: “To
our knowledge, no-one has previously reported a demonstration that
transgenic mosquitoes can exhibit a fitness advantage over non-
The modified mosquitoes had a higher survival rate and laid more eggs.
However, when both sets of insects were fed non-infected blood they
competed equally well.
For resistant mosquitoes to be useful in the wild, they must survive
better than non-resistant mosquitoes even when not exposed to malaria.
Even so, the researchers concluded: “The results have important
implications for implementation of malaria control by means of genetic
modification of mosquitoes.”
GM mosquitoes that interfered with development of the malaria parasite
would make it more difficult for the organism to become re-established
after it had been eradicated from a target area, they said.
Malaria, spread by the single-celled parasite Plasmodium, is endemic
in parts of Asia, Africa, and central and south America.
The organism is passed to humans through the bite of the Anopheles
mosquito. Each year it makes 300 million people ill and causes a
million deaths worldwide.
Some 90% of cases are in sub-Saharan Africa, where a child dies of
malaria every 30 seconds.
Dr Rasgon stressed that one area the team needed to look at further
was the type of malaria used in the experiments.
The mice were infected with Plasmodium berghei, which is specific to
rodents. There was a big difference, he said, between this parasite
and the species that blight humans; and the technique would have to be
demonstrated in those organisms as well.
“I think it will be 10 to 20 years before transgenic mosquitoes are
released into nature. It’s very difficult to predict what will happen
when we release these things,” he added.
“There is quite a lot of research that needs to be done, both in terms
of genetics and the ecology of the mosquitoes; and also research to
address all the social, ethical and legal issues associated with
releasing transgenic organisms into the environment.”
Commenting on the study, Professor Chris Curtis from the London School
of Hygiene and Tropical Medicine, UK, said many strategies would be
needed to combat malaria effectively.
Even if GM mosquitoes were shown to be effective in the first
instance, it was always possible that the parasite would evolve to
limit that success, he explained.
“There will obviously be strong selection pressure on the malaria
parasite to do that; and that’s a problem with anti-malaria drugs and
insecticides. We have to keep working to produce new tricks to try to
keep ahead of what the parasite will try to do,” he told BBC News.
He said his work in Tanzania had shown bednets laced with insecticide
were very effective in combating infections.